Get started
Author

Sara Puglioli

Observed names: Puglioli, Sara, S. Puglioli
ORCID: 0000-0002-4795-7331
Observed ORCID: 0000-0002-4795-7331
OpenAlex ID: A5005639696
Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library
2022 · Sara Puglioli, Eleonore Schmidt, et al. · Chem · 47
Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics
2022 · Laura Lucaroni, Tony Georgiev, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 45
A DNA-encoded chemical library based on chiral 4-amino-proline enables stereospecific isozyme-selective protein recognition
2023 · Sebastian Oehler, Laura Lucaroni, et al. · Nature Chemistry · 44
Design and synthesis of the first indole-based blockers of Panx-1 channel
2021 · Letizia Crocetti, Gabriella Guerrini, et al. · European Journal of Medicinal Chemistry · 17
Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors
2024 · Christian Pellegrino, Nicholas Favalli, et al. · OncoImmunology · 16
PDF
Impact of library input on the hit discovery rate in DNA-encoded chemical library selections
2023 · Sara Puglioli, Sebastian Oehler, et al. · Chemical Science · 12
PDF
PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al. · Molecular Cancer Therapeutics · 9
Permutational Encoding Strategy Accelerates HIT Validation from Single-Stranded DNA-Encoded Libraries
2024 · Sara Puglioli, Mosè Fabbri, et al. · Bioconjugate Chemistry · 1
Systematic Evaluation of Washing Conditions to Preserve Low Affinity Binders in DEL Selections
2026 · Mosè Fabbri, Lorenzo Campari, et al. · Bioconjugate Chemistry
Impact of Primer and Template Designs on PCR and NGS Performance in Single‐Stranded DNA‐Encoded Library Screening at Different Inputs
2026 · Maria Heinke, Mosè Fabbri, et al. · Chemistry - A European Journal
PDF
High-Throughput Binding Kinetic Measurements of DNA-Encoded Library-Derived Hits By Focal Molography
2026 · Nicholas Favalli, Carola Velti, et al. · Journal of Medicinal Chemistry
Aligning Molecular Graph Explanations with Chemical Identity via InChIfied Invariants
2026 · Guidotti, Emanuele, Puglioli, Sara · arXiv (Cornell University)
PDF
Supplementary Figure S4 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S5 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S11 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Table S1 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S14 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S8 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Information (SI) from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S16 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S10 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S9 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S2 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S1 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Supplementary Figure S15 from PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
2025 · Tony Georgiev, Sara Puglioli, et al.
Works count: 37
Citation count: 191
H-index: 7
I10-index: 6
Year
Topic
Type